An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts directly for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users administering substances of uncertain source.
Some professionals said the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Service Response and Content Removal
Based on the social media company, the service has removed violative material and banned related keywords and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in strengthening compliance measures.
Online Trading Activities
Investigations also discovered communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, filled with photos of weight loss, positive reviews and detailed guides for mixing or injecting at residence.
Within minutes of joining one group, a seller posted contact information, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Product Information and Costs
Inside these groups, posts show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram said it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering materials they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has already encountered patients injured by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to potentially significant health risks”.
